Taysha Gene Therapies Debt-to-Assets Ratio Growth & History (TSHA)

Taysha Gene Therapies's debt-to-assets ratio was 0.20 for fiscal 2025.

View full Taysha Gene Therapies company overview

Taysha Gene Therapies annual debt-to-assets ratio history

Taysha Gene Therapies annual debt-to-assets ratio

Fiscal yearPeriod endedDebt-to-assets ratioChangeGrowth
20252025-12-310.20−0.19−48.45%
20242024-12-310.400.04+10.63%
20232023-12-310.36−0.13−25.91%
20222022-12-310.480.31+178.17%
20212021-12-310.17

Taysha Gene Therapies debt-to-assets ratio trends

Between the periods ended 2021-12-31 and 2025-12-31, Taysha Gene Therapies's debt-to-assets ratio increased from 0.17 to 0.20, a change of 0.03. The latest reported quarter, Q2 2026, shows 0.12.

About the metric

What the debt-to-assets ratio means

The debt-to-assets ratio shows the portion of a company’s reported assets financed with interest-bearing debt. It is a leverage measure and should not be confused with total liabilities divided by assets.

Calculation and source

How debt-to-assets is calculated

TickerStat calculates debt-to-assets as total interest-bearing debt divided by total assets at the same reporting-period end. Periods with missing debt or non-positive assets are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Taysha Gene Therapies source filings ↗

Community posts

It’s quiet here.

No posts about TSHA yet. Start the conversation.

Write the first post